Phase I trial of M2ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 586-590

Spandidos Publications

Access to resources Recommend Favorite

Phase II study on the combination of irinotecan plus cisplatin as a secondline therapy in patients with advanced or recurrent gastric cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 749-752

Spandidos Publications

Access to resources Recommend Favorite

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

By Broxmeyer H.E.   Orazi A.   Hague N.L.   Sledge G.W.   Rasmussen H.   Beutler M.E.S.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 1, 1998-03 ,pp. : 14-30

Academic Press

Access to resources Recommend Favorite

Development of Tumor B-cell Lymphocyte Hybridoma (TBH) Autovaccination. Results of a Phase I-II Clinical Trial

By Moviglia G.A.  

Transfusion and Apheresis Science, Vol. 17, Iss. 4, 1996-12 ,pp. : 643-649

Elsevier

Access to resources Recommend Favorite

Development of Tumor B-cell Lymphocyte Hybridoma (TBH) Autovaccination. Results of a Phase I-II Clinical Trial

By Moviglia G.A.  

Transfusion Science, Vol. 17, Iss. 4, 1996-12 ,pp. : 643-649

Elsevier

Access to resources Recommend Favorite